Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Mahmoud El-Bendary"'
Publikováno v:
BMC Medical Genomics, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background The severity of chronic hepatitis C and susceptibility to hepatocellular carcinoma (HCC) are associated with genetic variations within vitamin D receptor (VDR) in several populations. This study aims to determine the significance
Externí odkaz:
https://doaj.org/article/b6eb8b6d81514822b658954fa3c8de73
Autor:
Mahmoud El-Bendary, Khaled Farid, Mohammad Arafa, Wagdi Elkashef, Talaat Abdullah, Ahmed El-Mesery
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 35, Iss 1, Pp 1-12 (2023)
Abstract Aims Both S100A4 and Glypican-3 have been known to be engaged in HCC development and progression. This study aimed to evaluate both S100A4 and GPC3 expression in HCC tissues as a prognostic markers. Methods Tissues from 70 patients of HCC in
Externí odkaz:
https://doaj.org/article/2ef4639993e64b27b78c3c69c29e568b
Autor:
Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elnakib, Ahmed Elhawary, Abdel-Hady El-Gilany, Hosam Zaghloul, Mohamed Elegezy
Publikováno v:
Journal of Advanced Research, Vol 54, Iss , Pp S5-S6 (2023)
Externí odkaz:
https://doaj.org/article/c4013004394049e6885e1a58a9e84d78
Autor:
Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elhawary, Abdel-Hady El-Gilany, Hosam Zaghloul, Mohamed Elegezy, Ahmed Elnakib
Publikováno v:
Journal of Advanced Research, Vol 54, Iss , Pp S3-S4 (2023)
Externí odkaz:
https://doaj.org/article/be89e5b4e3d043b9bfc1b0f7a2f9ecfc
Prognostic value of Alpha-Methyl acyl-Coenzyme A Racemase (AMACR) versus P53 in colorectal neoplasia
Autor:
Mahmoud El-Bendary, Mohamed Abd-Aziz, Walaa Shabana, Wagdi Elkashef, Mohamed Abdel-Fatah Hegazy
Publikováno v:
Journal of Advanced Research, Vol 54, Iss , Pp S5- (2023)
Externí odkaz:
https://doaj.org/article/17b84b422d574d0fafc1ebd1af8158b3
Autor:
Mahmoud El-Bendary, Mustafa Neamatallah, Hatem Elalfy, Tarek Besheer, Emily Kamel, Hend Mousa, Abdel-Hamid Eladl, Maged El-Setouhy, Abdel-Hady El-Gilany, Ahmed El-Waseef, Gamal Esmat
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 68-77 (2019)
Introduction and aim. Hepatitis C virus (HCV) infection is a global medical problem. HLA -DRB1 alleles have an important role in immune response against HCV. The aim of this study is to clarify the contribution of HLA -DRB1 alleles in HCV susceptibil
Externí odkaz:
https://doaj.org/article/a21819ed310c4ea8afa988c890717e89
Autor:
Ahmed M. Abd El-Khalek, Nehal Tharwat Mohammed El-Sayed, Hatem Elalfy, Tarek Besheer, Khaled Farid, Mohamed ElAgezy, Wagdi Elkashef, Ahmed Alhawarey, Mahmoud El-Bendary, Ali Hasan Elmokadem
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 49, Iss 3, Pp 797-803 (2018)
Introduction: Percutaneous treatment of simple or hydatid liver cysts is widely used in clinical practice and ethanol is the commonest sclerosant used. Abdominal discomfort and pain commonly occurs after ethanol injection which increase with increase
Externí odkaz:
https://doaj.org/article/f8a8b8d081784c3c9223a9d385461f59
Publikováno v:
Afro-Egyptian Journal of Infectious and Endemic Diseases. :402-409
Autor:
Walid E. Zahran, Hany M M Abdel Allah, Ahmed F. Soliman, Samir A. El-Masry, Mahmoud El-Bendary
Publikováno v:
Clinical and Experimental Medicine. 22:257-267
Identification of host genetic factors influencing the risk of developing hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection may help to refine patients’ selection to benefit from specific preventative measure
Autor:
Mohamed AbdAllah, Mahmoud Essam, Mohamed Samir Abd Elghafar, Tamer Elhadidy, Gamal Esmat, Marwa Salama, Tamer Elbaz, Mustafa Neamatallah, Mostafa Elshazly, Ahmed Cordie, Mahmoud El-Bendary, Wafaa El-Akel, Khaled Farid, Mohamed Elegezy, Adel El-Badrawy, Sherief Abd-Elsalam, Hatem Elalfy
Publikováno v:
Expert Review of Anti-infective Therapy. 20:291-295
Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating CO...